Product Data Sheet

CDK9-IN-29

Catalog No. A54285

main product photo
CDK9-IN-29 is a highly selective inhibitor of Cyclin-dependent kinase 9 (CDK9) with an IC50 value of 3.20 nM. This compound effectively hinders cell proliferation and promotes apoptosis in various cellular models. CDK9-IN-29 is suitable for research focused on cancer biology, particularly studies investigating transcriptional regulation and cell cycle dynamics.
Chemical Information
Catalog NumA54285
M. Wt553.60
FormulaC29H33F2N5O4
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2737262-24-5
Synonyms
SMILESFC1=C(C=C(C=C1)C2=C(C=NC(N3)=N2)F)OCCCCCCOC4=CC3=CC=C4C(NCCN5CCOCC5)=O
Biological Activity
DescriptionCDK9-IN-29 is a highly selective inhibitor of Cyclin-dependent kinase 9 (CDK9) with an IC50 value of 3.20 nM. This compound effectively hinders cell proliferation and promotes apoptosis in various cellular models. CDK9-IN-29 is suitable for research focused on cancer biology, particularly studies investigating transcriptional regulation and cell cycle dynamics.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.